{
  "instance_id": 197,
  "chat_eval": "1",
  "answer": "CNR1",
  "extracted_solution_or_last_step": "# Analysis of Causal Genes for Nausea in GWAS Locus\n\n## Executive Summary\n\nBased on comprehensive literature analysis, **CNR1** is identified as the most likely causal gene for nausea within the given locus containing AKIRIN2, CNR1, ORC3, RNGTT, and SPACA1.\n\n## Key Findings\n\n### CNR1 (Cannabinoid Receptor Type 1) - Strong Evidence\n\n**Direct Clinical Evidence:**\n- A randomized controlled trial demonstrated efficacy of cannabidiol in treating idiopathic and diabetic gastroparesis, which involves nausea and vomiting symptoms [1]\n- CNR1 polymorphisms are associated with cyclic vomiting syndrome, a condition characterized by severe nausea and vomiting episodes [2]\n\n**Neurobiological Mechanisms:**\n- CNR1 encodes the cannabinoid receptor type 1, a key component of the endocannabinoid system that regulates brain-gut axis function [3]\n- Anandamide transport inhibition (targeting CNR1 signaling) attenuates nausea-induced behavior in rats and vomiting in shrews [4]\n- Dexamethasone's anti-nausea effects partially involve enhancement of the endocannabinoid system [5]\n\n### Other Genes - No Supporting Evidence\n\n**AKIRIN2:** Literature search revealed associations with immune defense in fish, growth traits in cattle, and anxiety disorders, but no direct connections to nausea\n\n**ORC3:** Found associations with cell cycle regulation and cancer resistance, but no nausea-related connections\n\n**RNGTT:** Limited to mRNA processing mechanisms and cancer transcriptional programs, with no nausea associations\n\n**SPACA1:** Papers focused on sperm function and male infertility, with no relation to nausea\n\n## Scientific Rationale\n\nThe endocannabinoid system, particularly CNR1 signaling, has well-established roles in nausea and vomiting regulation through:\n\n1. **Brain-gut axis modulation**: Direct communication between central and peripheral nervous systems controlling emesis\n2. **Chemoreceptor trigger zone regulation**: Control of the area postrema that detects emetic stimuli\n3. **Dopamine and serotonin receptor interactions**: Key neurotransmitters involved in nausea control\n4. **Clinical therapeutic applications**: Cannabinoids used to treat nausea in cancer patients\n\n## Conclusion\n\n**CNR1** emerges as the clear candidate for the causal gene of nausea based on convergent clinical and experimental evidence demonstrating direct involvement in nausea and vomiting pathways.\n\n---\n\n*References:*\n[1] Clinical gastroenterology and hepatology, PMID: 37482172\n[2] The American journal of gastroenterology, PMID: 28349993  \n[3] Gastroenterology, PMID: 27133395\n[4] British journal of pharmacology, PMID: 23991698\n[5] European journal of pharmacology, PMID: 24508383",
  "error": null,
  "last_200_tokens": "**AKIRIN2:** Literature search revealed associations with immune defense in fish, growth traits in cattle, and anxiety disorders, but no direct connections to nausea **ORC3:** Found associations with cell cycle regulation and cancer resistance, but no nausea-related connections **RNGTT:** Limited to mRNA processing mechanisms and cancer transcriptional programs, with no nausea associations **SPACA1:** Papers focused on sperm function and male infertility, with no relation to nausea ## Scientific Rationale The endocannabinoid system, particularly CNR1 signaling, has well-established roles in nausea and vomiting regulation through: 1. **Brain-gut axis modulation**: Direct communication between central and peripheral nervous systems controlling emesis 2. **Chemoreceptor trigger zone regulation**: Control of the area postrema that detects emetic stimuli 3. **Dopamine and serotonin receptor interactions**: Key neurotransmitters involved in nausea control 4. **Clinical therapeutic applications**: Cannabinoids used to treat nausea in cancer patients ## Conclusion **CNR1** emerges as the clear candidate for the causal gene of nausea based on convergent clinical and experimental evidence demonstrating direct involvement in nausea and vomiting pathways. --- *References:* [1] Clinical gastroenterology and hepatology, PMID: 37482172 [2] The American journal of gastroenterology, PMID: 28349993 [3] Gastroenterology, PMID: 27133395 [4] British journal of pharmacology, PMID: 23991698 [5] European journal of pharmacology, PMID: 24508383 </solution>",
  "answer_count_in_last_200_tokens": 2,
  "potential_answer_with_has_is": "CNR1",
  "potential_answer_final_answer": null,
  "potential_answer_conclusion": "CNR1",
  "potential_answer_emerges": "CNR1",
  "count_potential_answer_with_has_is": 8,
  "count_potential_answer_final_answer": 0,
  "count_potential_answer_conclusion": 8,
  "count_potential_answer_emerges": 8,
  "prompt": "Your task is to identify likely causal genes within a locus for a given GWAS phenotype. From the list, provide only the likely causal gene (matching one of the given genes). \nIdentify the causal gene.\nGWAS phenotype: Nausea\nGenes in locus: {AKIRIN2},{CNR1},{ORC3},{RNGTT},{SPACA1}\n",
  "task_name": "gwas_causal_gene_pharmaprojects",
  "execution_time": 2271.317666530609
}